Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pelvic and Thoracic Cancer Treated With Online Adapted Radiotherapy: A Prospective Registry-based Phase-II Trial

NCT06185062 is registered in ClinicalTrials.gov with University Medical Center Goettingen as lead sponsor.

NCT NCT06185062
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06185062 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pelvic and Thoracic Cancer Treated With Online Adapted Radiotherapy: A Prospective Registry-based Phase-II Trial
Lead sponsor
University Medical Center Goettingen
Phase
Observational
Overall status
Recruiting
Start date
January 1, 2024
Completion date
April 30, 2030
Enrollment
846 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pelvic tumor, thoracic tumor